Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004097-15Phase 4Completed
Phase 4, randomised, double-blind trial of midazolam in nociceptive pain (3 arms), sponsored by Klinik Ottakring. Primary endpoint: Primary analgesic efficacy by suprathreshold heat pain ratings. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004097-15.